| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.ATV.0000191635.00744.B6 |
| P698 | PubMed publication ID | 16239599 |
| P2093 | author name string | Jun Ren | |
| Xiaoping Yang | |||
| Xiaochun Zhang | |||
| William J Murdoch | |||
| Brenda M Alexander | |||
| Nair Sreejayan | |||
| David A Tulis | |||
| D Paul Thomas | |||
| Bruce W Culver | |||
| Mysore N A Rao | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | curcumin | Q312266 |
| P304 | page(s) | 85-90 | |
| P577 | publication date | 2005-10-20 | |
| P1433 | published in | Arteriosclerosis, Thrombosis, and Vascular Biology | Q4797542 |
| P1476 | title | Curcumin inhibits platelet-derived growth factor-stimulated vascular smooth muscle cell function and injury-induced neointima formation | |
| P478 | volume | 26 |
| Q37175528 | AMP-activated protein kinase inhibits vascular smooth muscle cell proliferation and migration and vascular remodeling following injury |
| Q38118993 | Advanced glycation end-products: a common pathway in diabetes and age-related erectile dysfunction |
| Q38732481 | An overview of structure-activity relationship studies of curcumin analogs as antioxidant and anti-inflammatory agents |
| Q37193830 | Antigrowth properties of BAY 41-2272 in vascular smooth muscle cells |
| Q39293061 | Attenuation of endothelin-1-induced PKB and ERK1/2 signaling, as well as Egr-1 expression, by curcumin in A-10 vascular smooth muscle cells |
| Q42957166 | Baicalin inhibits PDGF-BB-stimulated vascular smooth muscle cell proliferation through suppressing PDGFRβ-ERK signaling and increase in p27 accumulation and prevents injury-induced neointimal hyperplasia |
| Q39550187 | Berberine cooperates with adrenal androgen dehydroepiandrosterone sulfate to attenuate PDGF-induced proliferation of vascular smooth muscle cell A7r5 through Skp2 signaling pathway |
| Q42859208 | Bisdemethoxycurcumin inhibits PDGF-induced vascular smooth muscle cell motility and proliferation |
| Q35838938 | Butylated hydroxyanisole stimulates heme oxygenase-1 gene expression and inhibits neointima formation in rat arteries |
| Q36819371 | Cancer cell signaling pathways targeted by spice-derived nutraceuticals |
| Q38975030 | Chemopreventive effects of curcumin on chemically induced mouse skin carcinogenesis in BK5.insulin-like growth factor-1 transgenic mice |
| Q35270041 | Cilostazol Inhibits Vascular Smooth Muscle Cell Proliferation and Reactive Oxygen Species Production through Activation of AMP-activated Protein Kinase Induced by Heme Oxygenase-1. |
| Q34624184 | Colorectal cancer: chemopreventive role of curcumin and resveratrol |
| Q36870967 | Curcumin Exerts its Anti-hypertensive Effect by Down-regulating the AT1 Receptor in Vascular Smooth Muscle Cells |
| Q36570080 | Curcumin ameliorates arterial dysfunction and oxidative stress with aging |
| Q39209459 | Curcumin ameliorates the neurodegenerative pathology in A53T α-synuclein cell model of Parkinson's disease through the downregulation of mTOR/p70S6K signaling and the recovery of macroautophagy |
| Q39569574 | Curcumin and a Morus alba extract reduce pro-inflammatory effects of resistin in human endothelial cells |
| Q38871530 | Curcumin and insulin resistance-Molecular targets and clinical evidences. |
| Q50231581 | Curcumin attenuates osteogenic differentiation and calcification of rat vascular smooth muscle cells. |
| Q34672128 | Curcumin inhibits angiogenesis and improves defective hematopoiesis induced by tumor-derived VEGF in tumor model through modulating VEGF-VEGFR2 signaling pathway |
| Q52881618 | Curcumin reduces cardiac fibrosis by inhibiting myofibroblast differentiation and decreasing transforming growth factor β1 and matrix metalloproteinase 9 / tissue inhibitor of metalloproteinase 1. |
| Q34163076 | Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma. |
| Q34589151 | Curcumin: from ancient medicine to current clinical trials. |
| Q46870633 | Cytostatic drugs differentially affect phenotypic features of porcine coronary artery smooth muscle cell populations |
| Q50901167 | DNA enzyme ED5 depletes egr-1 and inhibits neointimal hyperplasia in rats. |
| Q42797471 | Dysregulation of the ubiquitin-proteasome system by curcumin suppresses coxsackievirus B3 replication |
| Q54584352 | Effect of N-(p-coumaroyl)serotonin and N-feruloylserotonin, major anti-atherogenic polyphenols in safflower seed, on vasodilation, proliferation and migration of vascular smooth muscle cells. |
| Q34617929 | Effect of curcumin against oxidation of biomolecules by hydroxyl radicals |
| Q36916621 | Experimental Rat and Mouse Carotid Artery Surgery: Injury & Remodeling Studies. |
| Q35159534 | Expression of platelet-derived growth factor in the vascular walls of patients with lower extremity arterial occlusive disease |
| Q28535681 | Genipin inhibits TNF-α-induced vascular smooth muscle cell proliferation and migration via induction of HO-1 |
| Q51032084 | Goniolactone C, a styryl lactone derivative, inhibits PDGF-BB-induced vascular smooth muscle cell migration and proliferation via PDGFR/ERK signaling. |
| Q36352070 | Inhibition of vascular smooth muscle growth via signaling crosstalk between AMP-activated protein kinase and cAMP-dependent protein kinase |
| Q39174244 | Insulin-like growth-factor-1-induced PKB signaling and Egr-1 expression is inhibited by curcumin in A-10 vascular smooth muscle cells |
| Q34583622 | Lifestyle and dietary influences on nosebleed severity in hereditary hemorrhagic telangiectasia |
| Q38045211 | Molecular mechanisms of curcumin action: gene expression |
| Q38367452 | Naturally occurring PDGF receptor inhibitors with potential anti-atherosclerotic properties. |
| Q28578929 | PYK2 signaling is required for PDGF-dependent vascular smooth muscle cell proliferation |
| Q36933273 | Paeonia lactiflora Extract Attenuating Cerebral Ischemia and Arterial Intimal Hyperplasia Is Mediated by Paeoniflorin via Modulation of VSMC Migration and Ras/MEK/ERK Signaling Pathway |
| Q26778562 | Phytochemical Compounds and Protection from Cardiovascular Diseases: A State of the Art |
| Q58572444 | Plant-Derived Products for Treatment of Vascular Intima Hyperplasia Selectively Inhibit Vascular Smooth Muscle Cell Functions |
| Q37286692 | Polyphenols: benefits to the cardiovascular system in health and in aging |
| Q34594807 | Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases |
| Q52641505 | Presenting a New Standard Drug Model for Turmeric and Its Prized Extract, Curcumin. |
| Q39906629 | Release and activity of anti-TNFalpha therapeutics from injectable chitosan preparations for local drug delivery |
| Q83653884 | Salvianolic acid A inhibits PDGF-BB induced vascular smooth muscle cell migration and proliferation while does not constrain endothelial cell proliferation and nitric oxide biosynthesis |
| Q53092489 | Shh mediates PDGF-induced contractile-to-synthetic phenotypic modulation in vascular smooth muscle cells through regulation of KLF4. |
| Q38930264 | Sirtuins, a promising target in slowing down the ageing process. |
| Q33914440 | Synthesis of 86 species of 1,5-diaryl-3-oxo-1,4-pentadienes analogs of curcumin can yield a good lead in vivo |
| Q86935540 | The potential efficacy of R8-modified paclitaxel-loaded liposomes on pulmonary arterial hypertension |
| Q50469562 | The relaxant effect of curcumin on porcine coronary arterial ring segments. |
| Q35429867 | The soluble guanylate cyclase stimulator BAY 41-2272 inhibits vascular smooth muscle growth through the cAMP-dependent protein kinase and cGMP-dependent protein kinase pathways |
| Q90269849 | Therapeutic Applications of Curcumin Nanomedicine Formulations in Cardiovascular Diseases |
| Q38156409 | Therapeutic effects of traditional herbal medicine on cerebral ischemia: a perspective of vascular protection |
| Q53155421 | Tunicamycin inhibits PDGF-BB-induced proliferation and migration of vascular smooth muscle cells through induction of HO-1. |
| Q41109128 | Vascular Stem/Progenitor Cell Migration Induced by Smooth Muscle Cell-Derived Chemokine (C-C Motif) Ligand 2 and Chemokine (C-X-C motif) Ligand 1 Contributes to Neointima Formation |
| Q90073542 | [Effects of platelet-derived growth factor on nerve regeneration around implant in rats] |
Search more.